Response of Recurrent GBM to Immune Checkpoint Inhibition
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Immune Checkpoint Inhibition for Hypermutant Glioblastoma Multiforme Resulting From Germline Biallelic Mismatch Repair Deficiency
J. Clin. Oncol 2016 Mar 21;[EPub Ahead of Print], E Bouffet, V Larouche, BB Campbell, D Merico, R de Borja, M Aronson, C Durno, J Krueger, V Cabric, V Ramaswamy, N Zhukova, G Mason, R Farah, S Afzal, M Yalon, G Rechavi, V Magimairajan, MF Walsh, S Constantini, R Dvir, R Elhasid, A Reddy, M Osborn, M Sullivan, J Hansford, A Dodgshun, N Klauber-Demore, L Peterson, S Patel, S Lindhorst, J Atkinson, Z Cohen, R Laframboise, P Dirks, M Taylor, D Malkin, S Albrecht, RW Dudley, N Jabado, CE Hawkins, A Shlien, U TaboriFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.